ProFound AI
Discover the ProFound impact of artificial intelligence for digital breast tomosynthesis
FDA Cleared, CE Mark, Health Canada Licensed
Discover the Xoft Electronic Brachytherapy (eBx) System
Explore Breakthrough Technology Delivering Excellent Results
<
>
Who is iCAD?
iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.
Recent News
December 4, 2019
iCAD’s ProFound AI Joins Nuance AI Marketplace for Diagnostic Imaging
December 2, 2019
iCAD to Showcase Leading Breast Health Solutions Suite Including Expanded ProFound AI™ Platform at RSNA Annual Meeting
November 26, 2019
iCAD to Participate at the Piper Healthcare Conference
November 18, 2019
iCAD to Participate at the Cannacord Genuity Medtech & Diagnostics Forum
October 30, 2019
iCAD Reports Financial and Operating Results for the Third Quarter and Nine Months Ended September 30, 2019
» View All News »
CONNECT
© 2018, iCAD Inc. All rights reserved. iCAD, the iCAD logo,, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.
